Literature DB >> 1831218

Co-stimulation of T cell proliferation by transforming growth factor-beta 1.

H M Lee1, S Rich.   

Abstract

Transforming growth factor-beta (TGF-beta) exhibits diverse regulatory roles in the immune system and has been described as a potent inhibitor of lymphocyte and hemopoietic progenitor cell growth. The present studies investigated the effects of TGF-beta 1 on murine T cell proliferation triggered through the T cell receptor/CD3 complex. In contrast to previously reported T cell growth inhibition, TGF-beta 1 costimulated splenic T cell proliferation in the presence of immobilized anti-CD3 antibody 2C11, with maximal effect at anti-CD3 concentration of 50 micrograms/ml. Although TGF-beta 1 induced a modest increase in IL-2R display, TGF-beta 1 co-stimulated proliferation was largely independent of IL-2 and/or IL-4. Anti-IL-2 and/or anti-IL-4 antibody did not significantly block the TGF-beta 1 co-stimulated T cell growth, and no IL-2 or IL-4 bioactivity was detected in TGF-beta 1 co-stimulated cultures. TGF-beta 1 did not enhance IL-2 mRNA expression beyond control levels. However, TGF-beta 1 co-stimulation caused an accelerated evolution of a memory or mature T cell population phenotype. Both CD4+ and CD8+ T cell subsets were significantly enriched for cells of the mature CD45RBloPgp-1hi phenotype, in comparison with T cells stimulated by anti-CD3 alone or with PMA, and CD8+ T cells predominated. These results thus provide initial evidence that TGF-beta 1 is capable of bifunctional T cell growth regulation, which occurs largely via an IL-2- and IL-4-independent pathway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831218

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Circulating immunoglobulin-bound transforming growth factor beta at a late tumour-bearing stage impairs antigen-specific responses of CD4+ T cells.

Authors:  M Harada; K Tatsugami; M Nomoto; K Nomoto
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Regulation of cytokine production by human Th0 cells following stimulation with peptide analogues: differential expression of TGF-beta in activation and anergy.

Authors:  D C Tsitoura; C M Gelder; D M Kemeny; J R Lamb
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

3.  Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells.

Authors:  H K Sillett; S M Cruickshank; J Southgate; L K Trejdosiewicz
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

4.  Inhibitory effects of transforming growth factor-beta (TGF-beta) on certain functions of intraepithelial lymphocytes.

Authors:  E C Ebert
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

5.  Effect of transforming growth factor beta on experimental Salmonella typhimurium infection in mice.

Authors:  M Galdiero; A Marcatili; G Cipollaro de l'Ero; I Nuzzo; C Bentivoglio; M Galdiero; C Romano Carratelli
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

6.  LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice.

Authors:  H Lu; C W Smith; J Perrard; D Bullard; L Tang; S B Shappell; M L Entman; A L Beaudet; C M Ballantyne
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

7.  Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1.

Authors:  J E Sligh; C M Ballantyne; S S Rich; H K Hawkins; C W Smith; A Bradley; A L Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

8.  Production of an early release, M(r) 36,000 monokine by stimulated rat macrophages.

Authors:  N M Hedberg; N Hunter; C Soussou; A E Knop
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

Review 9.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

10.  Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.

Authors:  G Bellone; A Turletti; E Artusio; K Mareschi; A Carbone; D Tibaudi; A Robecchi; G Emanuelli; U Rodeck
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.